Actively Recruiting
Prognostic Role of Macular Neovascular Membrane Subtype in Pneumatic Displacement of Macular Hemorrhages
Led by Marco Mazzola · Updated on 2026-02-23
60
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study investigates the prognostic value of macular neovascularization (MNV) subtypes in patients treated with pneumatic displacement for submacular hemorrhage. The researchers will compare anatomical and functional outcomes (visual acuity) between PCV, RAP, and other MNV forms within a Caucasian cohort to identify subtype-specific predictors of recovery.
CONDITIONS
Official Title
Prognostic Role of Macular Neovascular Membrane Subtype in Pneumatic Displacement of Macular Hemorrhages
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing pneumatic displacement for submacular hemorrhage caused by macular neovascularization
- Age 50 years or older at submacular hemorrhage diagnosis
- Caucasian ethnicity
- Submacular hemorrhage involving the central or internal ring of the ETDRS grid (within 3 mm of the fovea)
- Submacular hemorrhage size equal to or larger than one papillary diameter
- Pneumatic displacement treatment performed within 36 hours of diagnosis
You will not qualify if you...
- Submacular hemorrhage present for more than 15 days at diagnosis
- Submacular hemorrhage caused by conditions other than macular neovascularization
- Proliferative diabetic retinopathy in the study eye
- Aphakia in the study eye
- Inadequate pupil dilation, media opacities, or other barriers to retinal imaging
- Previous pneumatic displacement procedures for submacular hemorrhage in the study eye
- Eye surgery in the 8 weeks before pneumatic displacement
- Follow-up less than 6 months after the procedure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ospedale Santa Chiara Di Trento
Trento, Trento, Italy, 38122
Actively Recruiting
Research Team
M
marco mazzola, medical doctor
CONTACT
T
tommaso brighenti, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here